Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atherosclerosis | 19 | 2023 | 3419 | 1.830 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 10 | 2022 | 3249 | 1.140 |
Why?
|
Coronary Artery Disease | 11 | 2023 | 6544 | 1.090 |
Why?
|
Medication Adherence | 9 | 2021 | 2190 | 0.980 |
Why?
|
Cardiovascular Diseases | 19 | 2023 | 15645 | 0.920 |
Why?
|
Peripheral Arterial Disease | 4 | 2021 | 1308 | 0.720 |
Why?
|
Cardiology | 5 | 2023 | 1696 | 0.700 |
Why?
|
Rheumatic Fever | 1 | 2020 | 73 | 0.680 |
Why?
|
Veterans | 7 | 2023 | 2667 | 0.670 |
Why?
|
Myocardial Ischemia | 6 | 2023 | 2132 | 0.650 |
Why?
|
Echocardiography, Stress | 1 | 2020 | 137 | 0.640 |
Why?
|
Drug-Eluting Stents | 3 | 2019 | 680 | 0.600 |
Why?
|
Myocardial Infarction | 10 | 2023 | 11508 | 0.600 |
Why?
|
Healthcare Disparities | 5 | 2021 | 3407 | 0.550 |
Why?
|
Angina Pectoris | 2 | 2021 | 957 | 0.550 |
Why?
|
Absorbable Implants | 1 | 2019 | 333 | 0.540 |
Why?
|
Aortic Valve Insufficiency | 1 | 2021 | 575 | 0.530 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1366 | 0.530 |
Why?
|
Fibrinolytic Agents | 3 | 2020 | 2076 | 0.510 |
Why?
|
Shock, Cardiogenic | 5 | 2023 | 705 | 0.470 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2020 | 669 | 0.450 |
Why?
|
Periodicals as Topic | 2 | 2021 | 1463 | 0.420 |
Why?
|
Dyslipidemias | 1 | 2020 | 871 | 0.420 |
Why?
|
Heart Valve Prosthesis | 1 | 2021 | 1464 | 0.400 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2021 | 2769 | 0.390 |
Why?
|
Exercise Test | 1 | 2020 | 2185 | 0.390 |
Why?
|
Aspirin | 3 | 2020 | 3135 | 0.390 |
Why?
|
Guideline Adherence | 3 | 2020 | 2234 | 0.370 |
Why?
|
Ambulatory Care | 2 | 2020 | 2778 | 0.330 |
Why?
|
Antihypertensive Agents | 1 | 2018 | 2028 | 0.310 |
Why?
|
Risk Assessment | 9 | 2022 | 24275 | 0.300 |
Why?
|
United States Department of Veterans Affairs | 4 | 2021 | 937 | 0.300 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2020 | 2157 | 0.290 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2023 | 12235 | 0.290 |
Why?
|
Journal Impact Factor | 2 | 2019 | 157 | 0.280 |
Why?
|
Brain Ischemia | 1 | 2020 | 3000 | 0.280 |
Why?
|
Coronary Vessel Anomalies | 2 | 2021 | 308 | 0.260 |
Why?
|
Humans | 70 | 2023 | 765926 | 0.260 |
Why?
|
Behavioral Risk Factor Surveillance System | 6 | 2022 | 212 | 0.260 |
Why?
|
Treatment Outcome | 18 | 2023 | 65194 | 0.240 |
Why?
|
Telemedicine | 2 | 2021 | 3108 | 0.230 |
Why?
|
Substance-Related Disorders | 1 | 2021 | 4418 | 0.230 |
Why?
|
American Heart Association | 4 | 2023 | 1045 | 0.230 |
Why?
|
United States | 26 | 2023 | 72909 | 0.220 |
Why?
|
Sex Factors | 7 | 2021 | 10611 | 0.210 |
Why?
|
Hospital Mortality | 4 | 2021 | 5339 | 0.210 |
Why?
|
Secondary Prevention | 4 | 2022 | 1470 | 0.200 |
Why?
|
Ultrasonography, Interventional | 2 | 2023 | 1519 | 0.200 |
Why?
|
Risk Factors | 16 | 2022 | 74850 | 0.200 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7423 | 0.200 |
Why?
|
Colchicine | 2 | 2020 | 256 | 0.200 |
Why?
|
Prevalence | 6 | 2021 | 15828 | 0.190 |
Why?
|
Hypertension | 4 | 2021 | 8616 | 0.190 |
Why?
|
Vascular Diseases | 2 | 2021 | 1161 | 0.180 |
Why?
|
Cross-Sectional Studies | 9 | 2021 | 26282 | 0.180 |
Why?
|
Septal Occluder Device | 1 | 2022 | 126 | 0.180 |
Why?
|
Coronary Angiography | 3 | 2023 | 4498 | 0.180 |
Why?
|
Drug Prescriptions | 2 | 2020 | 1662 | 0.170 |
Why?
|
Coronary Disease | 3 | 2023 | 5919 | 0.170 |
Why?
|
Middle Aged | 21 | 2022 | 223016 | 0.170 |
Why?
|
Aged | 19 | 2022 | 171163 | 0.170 |
Why?
|
Foramen Ovale, Patent | 1 | 2022 | 209 | 0.160 |
Why?
|
Unsafe Sex | 1 | 2021 | 239 | 0.160 |
Why?
|
Male | 29 | 2023 | 363815 | 0.160 |
Why?
|
Budgets | 1 | 2020 | 232 | 0.150 |
Why?
|
Florida | 1 | 2020 | 416 | 0.150 |
Why?
|
Veterans Health | 1 | 2020 | 216 | 0.150 |
Why?
|
Acute Coronary Syndrome | 2 | 2021 | 2185 | 0.150 |
Why?
|
Female | 29 | 2022 | 396141 | 0.150 |
Why?
|
Herpes Zoster Oticus | 1 | 2017 | 7 | 0.150 |
Why?
|
Bibliometrics | 1 | 2021 | 356 | 0.140 |
Why?
|
Hypertriglyceridemia | 1 | 2021 | 292 | 0.140 |
Why?
|
Heart Failure | 5 | 2023 | 11837 | 0.140 |
Why?
|
Fever of Unknown Origin | 1 | 2018 | 94 | 0.140 |
Why?
|
Substance Abuse, Intravenous | 1 | 2021 | 527 | 0.130 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2018 | 125 | 0.130 |
Why?
|
Stroke | 5 | 2022 | 9739 | 0.130 |
Why?
|
Atrial Fibrillation | 3 | 2021 | 5186 | 0.120 |
Why?
|
Tobacco Use Disorder | 1 | 2021 | 708 | 0.120 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2020 | 396 | 0.120 |
Why?
|
Myocardial Revascularization | 1 | 2019 | 795 | 0.120 |
Why?
|
Age Factors | 6 | 2021 | 18382 | 0.120 |
Why?
|
Office Visits | 1 | 2019 | 594 | 0.120 |
Why?
|
Hypoglycemic Agents | 3 | 2022 | 3106 | 0.120 |
Why?
|
Vitamin K | 1 | 2017 | 312 | 0.120 |
Why?
|
Blood Pressure Determination | 1 | 2018 | 646 | 0.120 |
Why?
|
Drug Utilization | 1 | 2020 | 1187 | 0.110 |
Why?
|
Thrombolytic Therapy | 2 | 2020 | 2050 | 0.110 |
Why?
|
Peripheral Vascular Diseases | 1 | 2017 | 489 | 0.110 |
Why?
|
Anticoagulants | 3 | 2021 | 4856 | 0.110 |
Why?
|
Prosthesis Implantation | 1 | 2018 | 594 | 0.110 |
Why?
|
Adult | 15 | 2022 | 223088 | 0.110 |
Why?
|
Epidemiologic Methods | 1 | 2018 | 1325 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1318 | 0.110 |
Why?
|
Facial Paralysis | 1 | 2017 | 346 | 0.110 |
Why?
|
Patient Preference | 1 | 2020 | 947 | 0.100 |
Why?
|
Life Style | 2 | 2021 | 3928 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 10380 | 0.100 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 848 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1121 | 0.100 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 2023 | 283 | 0.100 |
Why?
|
Pandemics | 3 | 2021 | 8721 | 0.100 |
Why?
|
Coronary Stenosis | 1 | 2018 | 798 | 0.100 |
Why?
|
Mitral Valve Insufficiency | 1 | 2022 | 1415 | 0.100 |
Why?
|
Aged, 80 and over | 7 | 2021 | 59496 | 0.100 |
Why?
|
Anemia | 1 | 2021 | 1514 | 0.090 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2022 | 1563 | 0.090 |
Why?
|
Medicaid | 2 | 2021 | 2833 | 0.090 |
Why?
|
Registries | 3 | 2022 | 8346 | 0.090 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 994 | 0.090 |
Why?
|
Patient Readmission | 2 | 2022 | 3282 | 0.090 |
Why?
|
Alcoholism | 1 | 2021 | 1978 | 0.090 |
Why?
|
Heart Diseases | 1 | 2023 | 2818 | 0.090 |
Why?
|
Hodgkin Disease | 1 | 2018 | 1383 | 0.090 |
Why?
|
Tomography, Optical Coherence | 1 | 2023 | 2876 | 0.080 |
Why?
|
Hospitals | 1 | 2023 | 3886 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2021 | 1878 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2021 | 2307 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1943 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2782 | 0.080 |
Why?
|
Delivery of Health Care | 3 | 2021 | 5364 | 0.080 |
Why?
|
Mortality | 1 | 2020 | 2910 | 0.080 |
Why?
|
Comorbidity | 5 | 2021 | 10575 | 0.080 |
Why?
|
Internet | 1 | 2020 | 3106 | 0.070 |
Why?
|
Odds Ratio | 1 | 2020 | 9656 | 0.070 |
Why?
|
Attention | 1 | 2018 | 2413 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3690 | 0.070 |
Why?
|
Insurance, Health | 1 | 2020 | 2520 | 0.070 |
Why?
|
Endovascular Procedures | 1 | 2021 | 2219 | 0.070 |
Why?
|
Incidence | 3 | 2021 | 21513 | 0.070 |
Why?
|
Coronary Vessels | 1 | 2018 | 3094 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5531 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3928 | 0.070 |
Why?
|
Time Factors | 4 | 2021 | 40097 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2430 | 0.070 |
Why?
|
Hyperlipidemias | 2 | 2021 | 770 | 0.070 |
Why?
|
Stents | 1 | 2018 | 3191 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3930 | 0.070 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 2022 | 0.070 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3109 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4213 | 0.060 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3231 | 0.060 |
Why?
|
Stroke Volume | 1 | 2019 | 5595 | 0.060 |
Why?
|
Thrombosis | 1 | 2019 | 2955 | 0.060 |
Why?
|
Databases, Factual | 4 | 2021 | 8060 | 0.060 |
Why?
|
Catheter Ablation | 1 | 2017 | 2787 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5509 | 0.050 |
Why?
|
Hospitalization | 2 | 2021 | 10810 | 0.050 |
Why?
|
Primary Health Care | 1 | 2019 | 4736 | 0.050 |
Why?
|
Blood Pressure | 1 | 2018 | 8530 | 0.050 |
Why?
|
Biomedical Research | 1 | 2018 | 3458 | 0.050 |
Why?
|
Young Adult | 4 | 2022 | 59857 | 0.050 |
Why?
|
Phenylephrine | 1 | 2022 | 291 | 0.050 |
Why?
|
Aging | 1 | 2020 | 8725 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 41680 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 10843 | 0.040 |
Why?
|
Mediastinum | 1 | 2022 | 271 | 0.040 |
Why?
|
Tobacco, Smokeless | 1 | 2021 | 132 | 0.040 |
Why?
|
Hospital Charges | 1 | 2021 | 345 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6306 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2022 | 539 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 13082 | 0.040 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 5889 | 0.040 |
Why?
|
Limb Salvage | 1 | 2021 | 488 | 0.040 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 227 | 0.040 |
Why?
|
Geography | 1 | 2020 | 651 | 0.040 |
Why?
|
General Practice | 1 | 2019 | 101 | 0.040 |
Why?
|
Hyperbilirubinemia | 1 | 2018 | 74 | 0.040 |
Why?
|
Reed-Sternberg Cells | 1 | 2018 | 78 | 0.040 |
Why?
|
Diet, Sodium-Restricted | 1 | 2019 | 291 | 0.040 |
Why?
|
Hemorrhage | 2 | 2020 | 3466 | 0.030 |
Why?
|
Eicosapentaenoic Acid | 1 | 2020 | 565 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2019 | 441 | 0.030 |
Why?
|
Risk-Taking | 1 | 2021 | 1021 | 0.030 |
Why?
|
Vagus Nerve | 1 | 2017 | 458 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2021 | 1813 | 0.030 |
Why?
|
Chest Pain | 1 | 2021 | 1102 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3343 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1735 | 0.030 |
Why?
|
Employment | 1 | 2020 | 1107 | 0.030 |
Why?
|
Primary Prevention | 1 | 2021 | 1187 | 0.030 |
Why?
|
Mitral Valve | 1 | 2022 | 1475 | 0.030 |
Why?
|
Eosinophilia | 1 | 2018 | 553 | 0.030 |
Why?
|
Medicare | 2 | 2022 | 6815 | 0.030 |
Why?
|
Physicians, Primary Care | 1 | 2019 | 622 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22340 | 0.030 |
Why?
|
Educational Status | 1 | 2020 | 2510 | 0.030 |
Why?
|
Ischemia | 1 | 2021 | 1901 | 0.030 |
Why?
|
Anticholesteremic Agents | 1 | 2020 | 970 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2022 | 81537 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2395 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2022 | 2645 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 809 | 0.020 |
Why?
|
Information Dissemination | 1 | 2019 | 1142 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2018 | 2111 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2331 | 0.020 |
Why?
|
Self Report | 1 | 2022 | 3768 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4335 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3225 | 0.020 |
Why?
|
Qualitative Research | 1 | 2020 | 3136 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4016 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2563 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2963 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8492 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2749 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10727 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9351 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12059 | 0.020 |
Why?
|
Health Expenditures | 1 | 2020 | 2388 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6486 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2019 | 2084 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4248 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2018 | 3447 | 0.020 |
Why?
|
Communication | 1 | 2020 | 3908 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6766 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13273 | 0.020 |
Why?
|
Adolescent | 2 | 2022 | 88811 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12973 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29890 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18074 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39228 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54807 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11858 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 30192 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36547 | 0.010 |
Why?
|
Concepts
(225)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_